Leishmania antimony resistance/ susceptibility in Algerian foci

Algeria is one of the most endemic countries for cutaneous and visceral forms of leishmaniosis. Strikingly, with more than 21,000 annual cases of cutaneous leishmaniosis recorded in 2010, the disease has a major public health impact.

• Publication year

  2017

• Venue

  Unknown venue

• Publication date

  2017-09-28

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.17352/OJTM.000005
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Development of a Murine Infection Model with Leishmania killicki, Responsible for Cutaneous Leishmaniosis in Algeria: Application in Pharmacology

  2016cited by this paper
• A Review: The Current In Vivo Models for the Discovery and Utility of New Anti-leishmanial Drugs Targeting Cutaneous Leishmaniasis

  2015cited by this paper
• Simultaneous multi-parametric analysis of Leishmania and of its hosting mammal cells: A high content imaging-based method enabling sound drug discovery process.

  2015cited by this paper
• Remote sensing, land cover changes, and vector-borne diseases: use of high spatial resolution satellite imagery to map the risk of occurrence of cutaneous leishmaniasis in Ghardaïa, Algeria.

  2014cited by this paper
• Leishmaniases in Maghreb: an endemic neglected disease.

  2014cited by this paper
• Heterogeneity of Molecular Resistance Patterns in Antimony-Resistant Field Isolates of Leishmania Species from the Western Mediterranean Area

  2014cited by this paper
• First report of natural infection in hedgehogs with Leishmania major, a possible reservoir of zoonotic cutaneous leishmaniasis in Algeria.

  2014cited by this paper
• Epidemiology of Visceral Leishmaniasis in Algeria: An Update

  2014cited by this paper
• Transmission Potential of Antimony-Resistant Leishmania Field Isolates

  2014cited by this paper
• Simple Colorimetric Trypanothione Reductase-Based Assay for High-Throughput Screening of Drugs against Leishmania Intracellular Amastigotes

  2013cited by this paper
• Entomological investigation following the resurgence of human visceral leishmaniasis in southern Algeria.

  2013cited by this paper
• In vitro susceptibility to antimonials and amphotericin B of Leishmania infantum strains isolated from dogs in a region lacking drug selection pressure.

  2012cited by this paper
• [Spread of Leishmania major to the north of Algeria].

  2012cited by this paper
• [Study of 71 cases of visceral leishmaniasis diagnosed at the Mustapha University Hospital (Algiers) from 1998 to 2009].

  2012cited by this paper
• Leishmaniasis Worldwide and Global Estimates of Its Incidence

  2012cited by this paper
• Geographical distribution and epidemiological features of Old World Leishmania infantum and Leishmania donovani foci, based on the isoenzyme analysis of 2277 strains

  2012cited by this paper
• A combined luciferase imaging and reverse transcription polymerase chain reaction assay for the study of Leishmania amastigote burden and correlated mouse tissue transcript fluctuations

  2011cited by this paper
• First detection of Leishmania killicki (Kinetoplastida, Trypanosomatidae) in Ctenodactylus gundi (Rodentia, Ctenodactylidae), a possible reservoir of human cutaneous leishmaniasis in Tunisia

  2011cited by this paper
• Canine Leishmania infantum enzymatic polymorphism: a review including 1023 strains of the Mediterranean area, with special reference to Algeria.

  2011cited by this paper
• Phlebotomus sergenti (Parrot, 1917) identified as Leishmania killicki host in Ghardaïa, south Algeria.

  2011cited by this paper
• Visceral leishmaniasis: Experimental models for drug discovery

  2011cited by this paper
• How can we identify parasite genes that underlie antimalarial drug resistance?

  2011cited by this paper
• Metabolomics to Unveil and Understand Phenotypic Diversity between Pathogen Populations

  2010cited by this paper
• Drug Resistance in Leishmaniasis

  2010cited by this paper
• Current diagnosis and treatment of visceral leishmaniasis

  2010cited by this paper
• Treatment of visceral leishmaniasis in 2010: direction from Bihar State, India.

  2010cited by this paper
• Speciation analysis of Sb(III) and Sb(V) in antileishmaniotic drug using Dowex 1 x 4 resin from hydrochloric acid solution.

  2010cited by this paper
• Elevated levels of tryparedoxin peroxidase in antimony unresponsive Leishmania donovani field isolates.

  2010cited by this paper
• In vitro activity of anti-leishmanial drugs against Leishmania donovani is host cell dependent.

  2010cited by this paper
• Linking In Vitro and In Vivo Survival of Clinical Leishmania donovani Strains

  2010cited by this paper
• Comparison of gene expression patterns among Leishmania braziliensis clinical isolates showing a different in vitro susceptibility to pentavalent antimony

  2010cited by this paper
• Increase in the prevalence of canine leishmaniasis in urban Algiers (Algeria) following the 2003 earthquake

  2009cited by this paper
• Geographical distribution and epidemiological features of Old World cutaneous leishmaniasis foci, based on the isoenzyme analysis of 1048 strains

  2009cited by this paper
• In Vitro Susceptibilities of Leishmania donovani Promastigote and Amastigote Stages to Antileishmanial Reference Drugs: Practical Relevance of Stage-Specific Differences

  2009cited by this paper
• Imaging Leishmania development in their host cells.

  2009cited by this paper
• Gene expression modulation is associated with gene amplification, supernumerary chromosomes and chromosome loss in antimony-resistant Leishmania infantum

  2009cited by this paper
• Parasite susceptibility to amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV type 1 and Leishmania infantum.

  2009cited by this paper
• Modulation of gene expression in drug resistant Leishmania is associated with gene amplification, gene deletion and chromosome aneuploidy

  2008cited by this paper
• Canine leishmaniosis--new concepts and insights on an expanding zoonosis: part two.

  2008cited by this paper
• In Vitro Susceptibility of Field Isolates of Leishmania donovani to Miltefosine and Amphotericin B: Correlation with Sodium Antimony Gluconate Susceptibility and Implications for Treatment in Areas of Endemicity

  2008cited by this paper
• Clinical and parasite species risk factors for pentavalent antimonial treatment failure in cutaneous leishmaniasis in Peru.

  2008cited by this paper
• Canine leishmaniosis - new concepts and insights on an expanding zoonosis: part one.

  2008cited by this paper
• Leishmaniasis treatment—a challenge that remains: a review

  2008cited by this paper
• Zoonoses and Climate Variability

  2008cited by this paper
• A Proteomics Screen Implicates HSP83 and a Small Kinetoplastid Calpain-related Protein in Drug Resistance in Leishmania donovani Clinical Field Isolates by Modulating Drug-induced Programmed Cell Death*

  2007cited by this paper
• Characterization of natural antimony resistance in Leishmania donovani isolates.

  2007cited by this paper
• Advances and perspectives in Leishmania cell based drug-screening procedures.

  2007cited by this paper
• Drug policy for visceral leishmaniasis: a cost‐effectiveness analysis

  2007cited by this paper
• The role of dogs as reservoirs of Leishmania parasites, with emphasis on Leishmania (Leishmania) infantum and Leishmania (Viannia) braziliensis.

  2007cited by this paper
• Increased levels of thiols protect antimony unresponsive Leishmania donovani field isolates against reactive oxygen species generated by trivalent antimony

  2007cited by this paper
• Molecular mechanisms of antimony resistance in Leishmania.

  2007cited by this paper
• Resistance to antimony and treatment failure in human Leishmania (Viannia) infection.

  2006cited by this paper
• American tegumentary leishmaniasis: Is antimonial treatment outcome related to parasite drug susceptibility?

  2006cited by this paper
• Unresponsiveness to Glucantime Treatment in Iranian Cutaneous Leishmaniasis due to Drug-Resistant Leishmania tropica Parasites

  2006cited by this paper
• Role of ABC transporter MRPA, gamma-glutamylcysteine synthetase and ornithine decarboxylase in natural antimony-resistant isolates of Leishmania donovani.

  2006cited by this paper
• Treatment of canine Old World visceral leishmaniasis: a systematic review.

  2005cited by this paper
• Argonaute—a database for gene regulation by mammalian microRNAs

  2005cited by this paper
• Modulation in aquaglyceroporin AQP1 gene transcript levels in drug‐resistant Leishmania

  2005cited by this paper
• Présence de Leishmania infantum MON-24 chez le chien

  2004cited by this paper
• Canine leishmaniasis.

  2004cited by this paper
• Leishmania major LmACR2 Is a Pentavalent Antimony Reductase That Confers Sensitivity to the Drug Pentostam*

  2004cited by this paper
• Short report: Treatment failure due to mixed infection by different strains of the parasite Leishmania infantum.

  2004cited by this paper
• Reduction of anti-leishmanial pentavalent antimonial drugs by a parasite-specific thiol-dependent reductase, TDR1.

  2004cited by this paper
• Dual Action of Antimonial Drugs on Thiol Redox Metabolism in the Human Pathogen Leishmania donovani*

  2004cited by this paper
• [Leishmaniasis in Algiers: epidemiologic data].

  2003cited by this paper
• In vitro cultivation and characterization of axenic amastigotes of Leishmania.

  2001cited by this paper
• DNA Transformation of Leishmania infantum Axenic Amastigotes and Their Use in Drug Screening

  2001cited by this paper
• Monitoring drug resistance in leishmaniasis

  2001cited by this paper
• Resistance to treatment in Kala-azar: speciation of isolates from northeast India.

  2001cited by this paper
• Efficacy of second line drugs on antimonyl-resistant amastigotes of Leishmania infantum.

  2000cited by this paper
• Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani.

  1999cited by this paper
• Combination allopurinol and antimony treatment versus antimony alone and allopurinol alone in the treatment of canine leishmaniasis (96 cases).

  1999cited by this paper
• A retrospective clinical study of canine leishmaniasis in 150 dogs naturally infected by Leishmania infantum

  1997cited by this paper
• Use of an enzymatic micromethod to quantify amastigote stage of Leishmania amazonensis in vitro

  1997cited by this paper
• Co‐amplification of the γ‐glutamylcysteine synthetase gene gsh1 and of the ABC transporter gene pgpA in arsenite‐resistant Leishmania tarentolae

  1997cited by this paper
• Treatment of canine visceral leishmaniasis with allopurinol

  1995cited by this paper
• Trypanothione reductase from Leishmania donovani. Purification, characterisation and inhibition by trivalent antimonials.

  1995cited by this paper
• Phlebotomus (Larroussius) perfiliewi naturally infected with dermotropic Leishmania infantum at Tenes, Algeria.

  1993cited by this paper
• An in vitro model for screening antileishmanial drugs: the human leukaemia monocyte cell line, THP-1.

  1992cited by this paper
• Decreased sensitivity to meglumine antimoniate (Glucantime) of Leishmania infantum isolated from dogs after several courses of drug treatment.

  1992cited by this paper
• [Visceral leishmaniasis in Algeria. Cases reported of visceral leishmaniasis (1985-1990)].

  1992cited by this paper
• Failure of meglumine antimoniate to cure cutaneous lesions due to Leishmania major in Algeria.

  1986cited by this paper
• Leishmania tropica: quantitation of in vitro activity of antileishmanial agents by Giemsa staining, viability, and 3H-formycin B incorporation.

  1984cited by this paper
• Isolation of Leishmania major Yakimoff & Schokhor, 1914 from Psammomys obesus Gretzschmar, 1828 (Rodentia: Gerbillidae) in Algeria.

  1983cited by this paper

• Cutaneous leishmaniasis in Algeria: An expanding endemic disease.

  2025cites this paper
• Fatty Acid Profiles of Leishmania major Derived from Human and Rodent Hosts in Endemic Cutaneous Leishmaniasis Areas of Tunisia and Algeria

  2022cites this paper
• Sand Flies (Diptera: Psychodidae): Fauna and Ecology in the Northeast of Algeria

  2022cites this paper
• Tackling Drug Resistance and Other Causes of Treatment Failure in Leishmaniasis

  2022cites this paper